BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38009642)

  • 21. Association of the sickle cell trait and the ABO blood group with clinical severity of malaria in southwest Nigeria.
    Amodu OK; Olaniyan SA; Adeyemo AA; Troye-Blomberg M; Olumese PE; Omotade OO
    Acta Trop; 2012 Aug; 123(2):72-7. PubMed ID: 22503377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi.
    Johnston WT; Mutalima N; Sun D; Emmanuel B; Bhatia K; Aka P; Wu X; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Batumba M; Carpenter LM; Jaffe H; Molyneux EM; Goedert JJ; Soppet D; Newton R; Mbulaiteye SM
    Sci Rep; 2014 Jan; 4():3741. PubMed ID: 24434689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait.
    Williams TN; Mwangi TW; Wambua S; Peto TE; Weatherall DJ; Gupta S; Recker M; Penman BS; Uyoga S; Macharia A; Mwacharo JK; Snow RW; Marsh K
    Nat Genet; 2005 Nov; 37(11):1253-7. PubMed ID: 16227994
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Thiam F; Diop G; Coulonges C; Derbois C; Mbengue B; Thiam A; Nguer CM; Zagury JF; Deleuze JF; Dieye A
    PeerJ; 2022; 10():e13487. PubMed ID: 35811813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Falciparum malaria mortality in sub-Saharan Africa in the pretreatment era.
    Watson JA; White NJ; Dondorp AM
    Trends Parasitol; 2022 Jan; 38(1):11-14. PubMed ID: 34862145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration.
    Agerbaek MØ; Pereira MA; Clausen TM; Pehrson C; Oo HZ; Spliid C; Rich JR; Fung V; Nkrumah F; Neequaye J; Biggar RJ; Reynolds SJ; Tosato G; Pullarkat ST; Ayers LW; Theander TG; Daugaard M; Bhatia K; Nielsen MA; Mbulaiteye SM; Salanti A
    Int J Cancer; 2017 Apr; 140(7):1597-1608. PubMed ID: 27997697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron Supplementation.
    Goheen MM; Wegmüller R; Bah A; Darboe B; Danso E; Affara M; Gardner D; Patel JC; Prentice AM; Cerami C
    EBioMedicine; 2016 Dec; 14():123-130. PubMed ID: 27852523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphoma.
    Liu Z; Luo Y; Kirimunda S; Verboom M; Onabajo OO; Gouveia MH; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Dhudha H; Ayers LW; Bhatia K; Goedert JJ; Cole N; Luo W; Liu J; Manning M; Hicks B; Prokunina-Olsson L; Chagaluka G; Johnston WT; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Hsing AW; Mensah JE; Adjei AA; Hutchinson A; Carrington M; Yeager M; Blasczyk R; Chanock SJ; Raychaudhuri S; Mbulaiteye SM
    Commun Biol; 2024 Jan; 7(1):41. PubMed ID: 38182727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of clinical presentation and hematological indices in hospitalized sickle cell patients with severe Plasmodium falciparum malaria.
    Purohit P; Mohanty PK; Patel S; Das P; Panigrahi J; Das K
    J Infect Public Health; 2018; 11(3):321-325. PubMed ID: 28927555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
    Carpenter LM; Newton R; Casabonne D; Ziegler J; Mbulaiteye S; Mbidde E; Wabinga H; Jaffe H; Beral V
    Int J Cancer; 2008 Mar; 122(6):1319-23. PubMed ID: 18000823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.
    Karimi P; Birmann BM; Anderson LA; McShane CM; Gadalla SM; Sampson JN; Mbulaiteye SM
    Br J Haematol; 2018 May; 181(4):505-514. PubMed ID: 29676453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus infection of infants: implications of early age of infection on viral control and risk for Burkitt lymphoma.
    Rochford R
    Bol Med Hosp Infant Mex; 2016; 73(1):41-46. PubMed ID: 29421232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malaria in patients with sickle cell anaemia: burden, risk factors and outcome at the Laquintinie hospital, Cameroon.
    Eleonore NLE; Cumber SN; Charlotte EE; Lucas EE; Edgar MML; Nkfusai CN; Geh MM; Ngenge BM; Bede F; Fomukong NH; Kamga HLF; Mbanya D
    BMC Infect Dis; 2020 Jan; 20(1):40. PubMed ID: 31937250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative haematological parameters of HbAA and HbAS genotype children infected with Plasmodium falciparum malaria in Yemen.
    Albiti AH; Nsiah K
    Hematology; 2014 Apr; 19(3):169-74. PubMed ID: 24074341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.
    Moormann AM; Snider CJ; Chelimo K
    Curr Opin Infect Dis; 2011 Oct; 24(5):435-41. PubMed ID: 21885920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma.
    Mawson AR; Majumdar S
    Int J Cancer; 2017 Nov; 141(9):1849-1855. PubMed ID: 28707393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
    Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
    Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya.
    Peprah S; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Sumba PO; Masalu N; Kawira E; Magatti J; Kinyera T; Otim I; Legason ID; Nabalende H; Dhudha H; Ally H; Genga IO; Mumia M; Ayers LW; Pfeiffer RM; Biggar RJ; Bhatia K; Goedert JJ; Mbulaiteye SM
    Int J Cancer; 2020 Feb; 146(4):953-969. PubMed ID: 31054214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium falciparum infection in febrile Congolese children: prevalence of clinical malaria 10 years after introduction of artemisinin-combination therapies.
    Etoka-Beka MK; Ntoumi F; Kombo M; Deibert J; Poulain P; Vouvoungui C; Kobawila SC; Koukouikila-Koussounda F
    Trop Med Int Health; 2016 Dec; 21(12):1496-1503. PubMed ID: 27671736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of Burkitt lymphoma in Africa.
    Hämmerl L; Colombet M; Rochford R; Ogwang DM; Parkin DM
    Infect Agent Cancer; 2019; 14():17. PubMed ID: 31388351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.